Johns Hopkins surgeon and COVID contrarian Marty Makary selected to lead Trump’s FDA
President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.
‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and approval process in the U.S., but Makary we expect will promote technology and innovation in a way that offers some reprieve for those that feared a department more aligned with different virtues.
9h
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration ...
President-elect Donald Trump has announced several additional Cabinet nominations to positions involving national health, ...
Johns Hopkins surgeon Dr. Marty Makary is his choice for the FDA and Dr. Janette Nesheiwat is in line to be the next surgeon ...
Dr. Marty Makary says data misinterpretation and conventional thinking is not serving us well — and he wants to change that.
Marty Makary, who Trump nominated to lead the FDA and work with RFK Jr., opposed vaccine mandates during the pandemic.
President-elect Donald Trump’s transition team has zeroed in on Dr. Marty Makary as the top target to lead the FDA during his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback